Home ›
NPI 1811167232
NPI deactivated
1811167232
1811167232 was paid $2.06M by Medicaid between Jan 2018 and Mar 2024, across 9 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider info1811167232
33aNPI1811167232
33bProvider type—
28Total paid$2.06M
24GClaims28,988
24DCodes billed9
24AFirst – last monthJan 2018 – Mar 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,212 | $101K | |
| 2019 | 2,052 | $153K | |
| 2020 | 1,216 | $96K | |
| 2021 | 9,407 | $456K | |
| 2022 | 14,973 | $1.21M | |
| 2024incomplete | 128 | $39K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 12,753 | 7,969 | $808K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 39% | 7,128 | 3,149 | $800K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 17% | 7,329 | 3,452 | $343K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.7% | 561 | 460 | $56K |
| H2011 | Crisis intervention service, per 15 minutes | 1.7% | 82 | 19 | $34K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 128 | 120 | $12K |
| 99205 | Prolong outpt/office vis | <1% | 38 | 37 | $5K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 13 | 13 | $426.60 |
| 00000 | 0% | 956 | 148 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.